Gastroenterology
From the Journals
New Biologic Tulisokibart Beats Placebo in Ulcerative Colitis Trial
Researchers said this was the first rigorous study of a drug class with an entirely new mechanism of action that may be beneficial in other immune...
From the Journals
In Crohn’s Disease, Early Anti-TNF Levels May be Crucial
“Getting it right in induction is probably the most important part” of treating Crohn’s disease, said Dr. Miguel Regueiro.
Latest News
Race Adjustments in Algorithms Boost CRC Risk Prediction
“Removing race from colorectal screening predictors could reduce the number of Black patients recommended for screening.”
Conference Coverage
Sex and Gender Influence Outcomes in Colorectal Cancer
Sex differences have clear biological and pathophysiological consequences in oncology.
Feature
How the Future of Medicine Will Revolve Around Our Gut
In just a few years, AI models could predict gut microbial composition based on data such as dietary habits and household characteristics.
Feature
AI-Assisted Pathology Poised to Transform Liver Disease Care
The standardization and reproducibility offered by AI-driven technology could facilitate more consistent diagnoses across different healthcare...
From the Journals
Environmental Pollutants Play a Growing Role in IBD
Heavy and transition metals were associated with gut dysbiosis and overgrowth of undesirable species of microorganisms.
From the Journals
Cancer Risk: Are Pesticides the New Smoking?
A recent study evaluated cancer risks in the US population using a model that accounts for pesticide use and adjusts for various factors.
Latest News
A CRC Blood Test Is Here. What Does it Mean for Screening?
While an exciting option, the test has its pros and cons.
Feature
Five Steps to Improved Colonoscopy Performance
Adenoma detection rates can be highly variable due to different techniques, technical skills, pattern recognition, interpretation, and experience...
From the Journals
Fecal Immunochemical Test Performance for CRC Screening Varies Widely
Despite widespread use of FITs for CRC screening, there is limited data to help guide test selection.